- XFOR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
-
Institutional
- Shorts
X4 Pharmaceuticals (XFOR) Institutional ownership
Company Profile
Type | Filer | #Shares | Filed | For date | #Previous | %Chg | Prev. Date |
---|---|---|---|---|---|---|---|
13F-HR
|
Rhumbline Advisers | 178.73 k | 30 Jan 25 | 31 Dec 24 | 178.48 k | 0% | 30 Sep 24 |
13F-HR/A
|
Thrivent Trust Co of Tennessee | 8.52 k | 30 Jan 25 | 31 Dec 24 | 8.52 k | 0% | 30 Sep 24 |
13F-HR
|
Vontobel Holding | 75.00 k | 29 Jan 25 | 31 Dec 24 | 75.00 k | 0% | 30 Sep 24 |
13F-HR
|
Lazari Capital Management | 10.00 k | 24 Jan 25 | 31 Dec 24 | 13.00 k | -23% | 30 Sep 24 |
13F-HR
|
Thrivent Trust Co of Tennessee | 8.52 k | 22 Jan 25 | 31 Dec 24 | 8.52 k | 0% | 30 Sep 24 |
13F-HR
|
LexAurum Advisors | 16.00 k | 21 Jan 25 | 31 Dec 24 | 16.00 k | 0% | 30 Sep 24 |
13F-HR
|
SG Americas Securities | 183.15 k | 17 Jan 25 | 31 Dec 24 | 55.00 k | +233% | 30 Sep 24 |
13F-HR
|
Nisa Investment Advisors | 919.00 | 17 Jan 25 | 31 Dec 24 | 314.00 | +193% | 30 Sep 24 |
13F-HR/A
|
JPMorgan Chase & Co. | 72.96 k | 26 Dec 24 | 30 Sep 24 | 71.61 k | +2% | 30 Jun 24 |
13F-HR/A
|
JPMorgan Chase & Co. | 71.61 k | 26 Dec 24 | 30 Jun 24 | 48.27 k | +48% | 31 Mar 24 |
This data is updated daily from 13F, 13D and 13G SEC filings.
Faded values represent incomplete data for the quarter, where values have been used from the previous quarter for institutions that haven't filed updated data yet.
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.